PROK

ProKidney Corp.

4.06 USD
+0.00 (+0.12%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ProKidney Corp. stock is up 99.02% since 30 days ago. The next earnings date is May 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 May’s closed higher than April. In the last 3 Unusual Options Trades, there were 1 CALL, 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 May 15:29 19 Jul, 2024 2.50 CALL 295 362
17 May 14:49 18 Oct, 2024 5.00 PUT 120 1
17 May 14:59 18 Oct, 2024 5.00 PUT 191 1

About ProKidney Corp.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.